MICROVISION, INC. Stock Compensation Disclosure
| Year Ended December 31, | ||||||||||||
| 2025 | 2024 | 2023 | ||||||||||
| Research and development expense | $ | 2,577 | $ | 3,973 | $ | 6,531 | ||||||
| Sales, marketing, general and administrative expense | (1,876 | ) | 7,562 | 9,610 | ||||||||
| $ | 701 | $ | 11,535 | $ | 16,141 | |||||||
During the year ended December 31, 2025, $ million and $ million of expense previously recognized within sales, marketing, general and administrative expense was reversed related to the forfeiture of awards in connection with the CEO and CFO separations, respectively, that occurred during the same period.
Options Activity and Positions
| Options | Shares | Weighted-average exercise price | Weighted-average remaining contractual term (in years) | Aggregate intrinsic value (thousands) | ||||||||||||
| Outstanding as of December 31, 2022 | 945 | $ | 1.26 | $ | 1,137 | |||||||||||
| Granted | ||||||||||||||||
| Exercised | (191 | ) | 0.92 | |||||||||||||
| Forfeited or expired | (2 | ) | 0.28 | |||||||||||||
| Outstanding as of December 31, 2023 | 752 | $ | 1.35 | $ | 1,083 | |||||||||||
| Granted | ||||||||||||||||
| Exercised | (84 | ) | 0.73 | |||||||||||||
| Forfeited or expired | (2 | ) | 1.18 | |||||||||||||
| Outstanding as of December 31, 2024 | 666 | $ | 1.43 | $ | 185 | |||||||||||
| Granted | ||||||||||||||||
| Exercised | (14 | ) | ||||||||||||||
| Forfeited or expired | (50 | ) | ||||||||||||||
| Outstanding as of December 31, 2025 | 602 | $ | 1.40 | $ | 44 | |||||||||||
| Vested and expected to vest as of December 31, 2025 | 602 | $ | 1.40 | 44 | ||||||||||||
| Exercisable as of December 31, 2025 | 602 | $ | 1.40 | 44 | ||||||||||||
As of December 31, 2025, there is unrecognized share-based employee compensation related to stock options.
Restricted Stock Activity and Positions
| Shares | Weighted-average price | |||||||
| Unvested as of December 31, 2022 | 8,866 | $ | 3.85 | |||||
| Granted | 3,491 | 3.89 | ||||||
| Vested | (1,872 | ) | 6.98 | |||||
| Forfeited | (502 | ) | 7.47 | |||||
| Unvested as of December 31, 2023 | 9,983 | 3.09 | ||||||
| Granted | 9,234 | 1.26 | ||||||
| Vested | (4,537 | ) | 3.63 | |||||
| Forfeited | (1,767 | ) | 2.65 | |||||
| Unvested as of December 31, 2024 ¹ | 12,913 | 1.53 | ||||||
| Granted | 12,730 | 1.16 | ||||||
| Vested | (4,373 | ) | 1.59 | |||||
| Forfeited | (11,408 | ) | 1.34 | |||||
| Unvested as of December 31, 2025 | 9,862 | $ | 1.24 | |||||
| 1 | The number of unvested RSUs and PSUs and the weighted-average price as of December 31, 2024 reported in this Note has been adjusted to from and to $ from $, respectively, as reported in Note 9 of the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, due to the correction of an administrative error. The correction resulted in no change to the previously issued financial statements and the Company deem the administrative error not material from a quantitative or qualitative perspective. |
During the year ended December 31, 2025, the Company granted shares to non-executive employees for annual, short-term incentive, and new hire awards. These shares are valued based on the closing price of common stock on the dates of grant and vest immediately or over three or four years.
During the year ended December 31, 2025, the Company granted shares to non-employees. These shares are valued based on the closing price of common stock on the dates of grant and vest immediately.
During the year ended December 31, 2025, the Company granted shares to executive employees and directors for annual, short-term incentive, and long-term incentive awards. These shares are valued based on the closing price of common stock on the dates of grant and vest immediately, over one year, or over three years
As of December 31, 2025, unrecognized share-based compensation related to RSUs was $ million, which will be expensed over the next years. Unrecognized share-based compensation related to executive PSUs was $ million, which will be expensed over the next years.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 4, 2026 | Showing above |
| 2024 | Mar 26, 2025 | |
| 2023 | Feb 29, 2024 | |
| 2022 | Mar 2, 2023 | |
| 2021 | Mar 1, 2022 | |
| 2020 | Mar 15, 2021 | |
| 2019 | Mar 12, 2020 | |
| 2018 | Mar 6, 2019 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.